Federal Court Extends Deadlines in Drugmakers’ 340B Rebate Appeals

A Washington, D.C. federal appeals court has extended drugmaker filing deadlines and has pushed back oral arguments in litigation surrounding HRSA's authority to approve 340B rebates.
A federal appeals court in Washington, D.C. has extended a filing deadline and postponed oral arguments in the drug industry’s [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

AstraZeneca Sues Dakotas Over 340B Contract Pharmacy Access Laws

AstraZeneca filed federal lawsuits in North and South Dakota challenging their 340B contract pharmacy access laws.
Drugmaker AstraZeneca recently filed a pair of federal lawsuits seeking to block 340B contract pharmacy access laws in North and [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

State Contract Pharmacy Lawsuit Roundup: Updates in Missouri, Nebraska, Oklahoma and Rhode Island

Key briefs were filed recently in litigation over state 340B contract pharmacy laws in Missouri, Nebraska, Oklahoma and Rhode Island.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Federal Court Schedules Late-October Oral Arguments for Drugmaker 340B Rebate Appeals

A Washington, D.C. federal appeals court scheduled oral arguments for drugmakers' 340B rebate appeals.
A federal appeals court recently scheduled late-October oral arguments for the pivotal legal battle over 340B rebate models, but hospitals [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Health System, Insurer Appear to Settle Lawsuit Alleging Medicare Advantage 340B Underpayments

Humana and an Alabama health system jointly asked a federal court to dismiss their ongoing litigation related to Medicare Advantage 340B payments.
An Alabama health system and a large health insurer appear to have reached a settlement over allegations that the insurer’s [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Federal Judge Rejects Health System’s Bid for Interest on 340B Medicare Lump Sum Repayments

A federal district judge in Washington, D.C. ruled that an Alabama health system is not entitled to interest payments on CMS' 340B lump sum repayment remedy.
A federal judge in Washington, D.C. has rejected a University of Alabama Health System lawsuit seeking interest on Medicare’s lump [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Two Drugmakers Sue Maine Over 340B Contract Pharmacy Law; Key Lawmaker Condemns Move

Drugmakers AbbVie and Novartis recently challenged Maine's 340B contract pharmacy access law in federal court.
Two major drugmakers recently filed lawsuits challenging Maine’s new 340B contract pharmacy access law, drawing sharp criticism from an influential [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Two Drugmakers Sue Rhode Island Over 340B Contract Pharmacy Access Law

Drugmakers AbbVie and Novartis recently filed federal lawsuits challenging Rhode Island's new 340B contract pharmacy access law.
Two large pharmaceutical companies this week filed the first federal lawsuits challenging Rhode Island’s recently enacted 340B contract pharmacy access [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

State Contract Pharmacy Lawsuit Roundup: Briefs in Colorado, Tennessee, Utah and Hawaii

Key briefs were filed this week in state 340B contract pharmacy litigation in Colorado, Tennessee, Utah and Hawaii.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

In Unanimous Decision, Fed Appeals Court Reverses Lower Court Ruling and Allows 340B Antitrust Lawsuit Against Insulin Drugmakers to Advance

The U.S. 2nd Circuit Court of Appeals' 3-0 decision reversed a lower court’s 2024 ruling that had denied health centers' antitrust claims against four drug manufacturers that have placed contract pharmacy restrictions.
A federal appeals court ruled unanimously Wednesday that an antitrust class action lawsuit, in which two health clinics alleged four [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live